Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort.

Tianchen ZhaoTakamitsu Nishi-UchiFumiya OmataMorihito TakitaMoe KawashimaYoshitaka NishikawaChika YamamotoYurie KobashiTakeshi KawamuraKenji ShibuyaJunichiro KazamaRyuzaburo ShinehaMasaharu Tsubokura

Published in: BMJ open (2022)

We observed significantly reduced anti-SARS-CoV-2 S1 antibody and neutralising antibodies in haemodialysis patients compared with cohorts matched for duration after vaccination. Patients receiving haemodialysis should be carefully monitored for immunological responses to the vaccination and COVID-19 infection.

Keyphrases

end stage renal disease
sars cov
chronic kidney disease
peritoneal dialysis
ejection fraction
newly diagnosed
prognostic factors
immune response
patient reported outcomes
coronavirus disease
patient reported